My average purchase price is .50 so that shows how long I've been here but my impatience stems from we are so close to BLA and approval for HIV initially but to date nothing is completed. We then move to 22 other indications that I think will be treatable with LL, then Covid. Again I am a long investor but please get something completed. I'm not selling anything but where is the lapse in follow through and root cause analysis so we don't repeat mistakes before moving on to another indication? Expenditures without revenue isn't a sustainable model.

Good luck to us all